Abiopharma

Clinical trial NCT06659341 updates: 1. completion date: 2027-07-30 → 2027-09-06 2. primary completion date: 2027-01-11 → 2027-04-26

Clinical trial NCT07454889: start date: 2026-07-31 → 2026-09-15.

Clinical trial NCT07642284: start date: 2026-05-30 → 2026-09-08.

Clinical trial NCT06649539 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. collaborators added: Endo USA Inc., a Keenova Therapeutics Company 3. collaborators removed: Endo Pharmaceuticals

Clinical trial NCT05236036 updates: 1. primary completion date: 2026-01-12 → 2029-01-03 2. enrollment: 60 → 86 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05328908: enrollment: 770 → 769 participants.

Clinical trial NCT04771650 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2028-08-01 → 2026-03-16 3. primary completion date: 2027-04-25 → 2026-03-16 4. enrollment: 220 → 91 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03135847 updates: 1. completion date: 2026-06-01 → 2028-06-01 2. primary completion date: 2026-06-01 → 2028-06-01

Clinical trial NCT07419334: start date: 2026-06-01 → 2026-06-03.

Clinical trial NCT06071767: status: RECRUITING → SUSPENDED.

Clinical trial NCT05371964 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 36 → 30 participants 3. enrollment type: ESTIMATED → ACTUAL 4. allocation: NA → NON_RANDOMIZED

Clinical trial NCT05394064: enrollment: 8 → 9 participants.

Clinical trial NCT07310992 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-01-15 → 2026-03-03

Clinical trial NCT07706166 updates: 1. start date: 2026-08-01 → 2026-09-01 2. completion date: 2029-08-01 → 2029-09-01 3. primary completion date: 2029-08-01 → 2029-09-01

Clinical trial NCT07383506: start date: 2026-06-01 → 2026-07-23.